REFERENCES
- Tolley G, Kenkel D, Fabian R. Valuing health for policy: An economic approach. Chicago, IL: Chicago University Press, 1994.
- Sloan FA. Valuing Health Care. New York, NY: Cambridge University Press, 1996.
- Kenkel D. On valuing morbidity, cost effectiveness analysis, and being rude. J Health Econ 1997, 16:749–757.
- Johannesson M. Theory and methods of economic evaluation of health care. Dordrecht: Kluwer Academic Publishers, 1996.
- Hargreaves WA, Shumnway M, Hu TW, Cuffel B. Cost-Outcome Methods for Mental Health. San Diego, CA: Academic Press, 1998.
- Drummond MF, O'Brian JO, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programs. 2nd ed. Oxford: Oxford University Press, 1997.
- French MT, Salome HJ, Sindelar JL, McLellan AT. Benefit-cost analysis of addiction treatment: Methodological guidelines and empirical application using the DATCAP and ASI. Health Services Res 2002; 37(2):433–455.
- Zarkin GA, Galinis DN, French MT, Fountain DL, Ingram PW, Guyett JA. Financing strategies for drug abuse treatment programs. J Subst Abuse Treat 1995; 12(6):385–399.
- French MT, McGeary KA. Estimating the economic cost of substance abuse treatment. Health Econ 1997; 6(5):539–544.
- French MT. Economic evaluation of drug abuse treatment programs: methodology and findings. Am J Drug Alcohol Abuse 1995; 21(1):111–135.
- French MT. Economic evaluation of alcohol treatment services. Recent Dev Alcohol 2001; 15:209–228.
- Roebuck MC, French MT, McLellan AT. DATStats: results from 85 studies using the Drug Abuse Treatment Cost Analysis Program. J Subst Abuse Treat 2003; 25(1):51–57.
- Alexandre PK, Roebuck MC, French MT, Chitwood DD, McCoy CB. Problem drinking, health services utilization, and the cost of medical care. Recent Dev Alcohol 2001; 15:285–298.
- Alexandre PK, Roebuck MC, French MT, Barry M. The cost of residential addiction treatment in public housing. J Subst Abuse Treat 2003; 24(4):285–290.
- Bradley CJ, French MT, Rachal JV. Financing and cost of standard and enhanced methadone treatment. J Subst Abuse Treat 1994; 11(5):433–442.
- French MT, McGeary KA. Estimating the economic cost of substance abuse treatment. Health Econ 1997; 6(5):539–544.
- French MT, Dunlap LJ, Zarkin GA, McGeary KA, McLellan AT. A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). J Subst Abuse Treat 1997; 14(5):445–455.
- French MT, Roebuck MC, McLellan AT, Sindelar JL. Can the Treatment Services Review be used to estimate the costs of addiction and ancillary services? J Subst Abuse Treat 2000; 12(4):341–461.
- French MT, McGeary KA. Estimating the economic cost of substance abuse treatment. Health Econ 1997; 6(5):539–544.
- Shepard DS, Larson MJ, Hoffmann NG. Cost-effectiveness of substance abuse services. Implications for public policy. Psychiatric Clinics of North America 1999; 22(2):385–400.
- Barnett PG, Swindle RW. Cost-effectiveness of inpatient substance abuse treatment. Health Services Res 1997; 32(5):615–629.
- Anderson DW, Bowland BJ, Cartwright WS, Bassin G. Service-level costing of drug abuse treatment. J Subst Abuse Treat 1998; 15(3):201–211.
- Bradley CJ, French MT, Rachal JV. Financing and cost of standard and enhanced methadone treatment. J Subst Abuse Treat 1994; 11(5):433–442.
- Levin BL. Utilization and costs of substance abuse services within The HMO Group. HMO Practice 1993; 7(1):28–34.